Therefore, our next goal was to investigate whether silencing the NCAPH gene could enhance the sensitivity of PCa cells to PI3K/AKT/mTOR or cyclin-dependent kinase (CDK) inhibitors. The gene discussed is MTOR; the disease is posterior cortical atrophy.